At close: January 8 at 4:00:02 PM EST
After hours: 7:37:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-67,049.0000
-33,221.0000
-41,886.0000
-33,075.0000
-15,301.0000
Investing Cash Flow
41,136.0000
-20,127.0000
47,245.0000
-91,566.0000
6,900.0000
Financing Cash Flow
27,059.0000
66,230.0000
5,451.0000
110,025.0000
16,143.0000
End Cash Position
14,384.0000
26,028.0000
13,146.0000
2,336.0000
16,952.0000
Interest Paid Supplemental Data
146.0000
172.0000
54.0000
--
308.0000
Capital Expenditure
-57.0000
-4,215.0000
-1,641.0000
-192.0000
-202.0000
Issuance of Capital Stock
27,464.0000
66,519.0000
5,472.0000
109,952.0000
25,216.0000
Repayment of Debt
-484.0000
-394.0000
-66.0000
--
-9,083.0000
Free Cash Flow
-67,106.0000
-37,436.0000
-43,527.0000
-33,267.0000
-15,503.0000
12/31/2020 - 5/7/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CMMB Chemomab Therapeutics Ltd.
2.2200
-1.77%
RZLT Rezolute, Inc.
5.21
-4.05%
MIST Milestone Pharmaceuticals Inc.
2.2000
-0.90%
CRVS Corvus Pharmaceuticals, Inc.
5.65
-1.74%
STOK Stoke Therapeutics, Inc.
8.96
-3.76%
VOR Vor Biopharma Inc.
1.6300
-1.81%
LRMR Larimar Therapeutics, Inc.
3.7900
-4.29%
LSTA Lisata Therapeutics, Inc.
3.8000
+1.60%
VTYX Ventyx Biosciences, Inc.
2.2500
-10.71%
MREO Mereo BioPharma Group plc
3.7600
0.00%